NTRK3-AS1

Across TCGA pan-cancer cohorts, NTRK3-AS1 RNA differs between tumor and matched normal tissue in 5 of 18 cancer types tested, making tumor–normal expression one of NTRK3-AS1’s most consistent transcriptional readouts.

The strongest signal is observed in kidney renal papillary cell carcinoma (KIRP), where NTRK3-AS1 RNA is repressed in tumor relative to normal tissue. In most cancer types NTRK3-AS1 is over-expressed in tumor, although a few such as KIRP and KICH show the opposite, repressed pattern.

KIRP, KICH, and KIRC are the cancer types where NTRK3-AS1 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in NTRK3-AS1 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
KIRP	Male	All	−0.041	<.001	6	view →
KICH	All	All	−0.030	<.001	6	view →
KIRC	Male	II,III,IV	−0.017	<.001	5	view →
LUSC	All	II,III,IV	−0.009	.032	2	view →
LUAD	All	III,IV	−0.010	.041	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 5 strongest of 5 lineages.

NTRK3-AS1–KIRP

Open the KIRP breakdown →